
Dec 18, 2025 01:03 am UTC| Technology Business
Oracle shares fell more than 4% on Wednesday after a Financial Times report claimed that Blue Owl Capital, Oracles largest U.S. data center partner, decided not to support a planned $10 billion data center project in...

ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Dec 18, 2025 01:00 am UTC| Business
ANZ Group has announced that its newly appointed chief executive officer will forgo his short-term bonus this year following a strong shareholder backlash against the banks executive remuneration. The decision comes after...

OpenAI Explores Massive Funding Round at $750 Billion Valuation
Dec 18, 2025 00:46 am UTC| Business Technology
OpenAI, the company behind the widely used AI chatbot ChatGPT, has reportedly entered preliminary discussions with investors about a potential new funding round that could value the company at approximately $750 billion....

LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Dec 18, 2025 00:45 am UTC| Business
Shares of LG Energy Solution (LGES) fell sharply in early Thursday trading, dropping as much as 7.6%, after the South Korean battery manufacturer disclosed that Ford Motor had cancelled a planned electric vehicle (EV)...

Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Dec 18, 2025 00:44 am UTC| Politics Governance Business
A union-aligned investment group has urged major U.S. corporations including Amazon, Walmart and Google-parent Alphabet to explain how President Donald Trumps immigration policies are affecting their finances, workforce...

Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Dec 18, 2025 00:00 am UTC| Politics Technology Business
Republican lawmakers are raising alarms over potential U.S. national security risks after a Reuters report revealed that Intel evaluated advanced chipmaking equipment from ACM Research, a company with significant ties to...

Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Dec 17, 2025 07:02 am UTC| Business Health
Sanofi (EURONEXT: SAN) announced Wednesday that its investigational therapy, efdoralprin alfa, has received orphan drug designation from the European Medicines Agency (EMA) for the treatment of alpha-1 antitrypsin...
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.